Unlock the Editor’s Digest without spending a dime

Roula Khalaf, Editor of the FT, selects her favorite tales on this weekly e-newsletter.

Demand for personal medical insurance coverage within the UK is anticipated to rise this yr, in accordance with trade executives and unbiased analysts, because the junior medical doctors’ industrial action exhibits no signal of ending and NHS ready lists stay excessive.

Payouts for personal claims hit a report of virtually £3bn in 2022, the newest yr for which there’s full information, the Association of British Insurers stated. Independent analysis suggests the variety of Britons with medical insurance coverage has grown at a excessive single-digit annual charge in recent times.

Industry figures anticipate the expansion to proceed regardless of the price of dwelling disaster.

“We’re being told by the private medical insurers that they are taking on record numbers of customers and that is reflected in the data we receive from hospitals for how people are paying for their procedures,” stated Dr Ian Gargan, chief government of the Private Healthcare Information Network, an unbiased organisation that assesses the charges and efficiency of personal consultants and hospitals. “There were record numbers using insurance for their treatment in 2023.”

There had been 12,000 extra admissions paid for with non-public medical insurance coverage within the second quarter of 2023 in contrast with the identical interval in 2022, a 9 per cent enhance, PHIN stated.

Aviva, one of many largest suppliers of medical insurance within the UK, reported that its “protection and health” premium gross sales had been up 23 per cent within the third quarter of final yr in contrast with the identical interval in 2022.

David Furness, director of coverage and supply on the Independent Healthcare Providers Network, an trade physique, stated: “Nearly nine in 10 companies across the sector feel the market environment for private medical insurance-funded services is ‘very positive’ or ‘positive’ so independent providers are upbeat about the[ir] prospects.”

Some 46 per cent of respondents in a PHIN survey stated an incapacity to get fast remedy on the NHS was an element of their determination to hunt non-public care.

The ready checklist for routine NHS hospital remedy in England has fallen barely from a report 7.77mn remedies on the finish of September to 7.6mn two months later. But the median referral-to-treatment time for such care virtually doubled from 7.5 weeks in February 2020 to 14.7 weeks in September 2023, in accordance with evaluation of NHS figures by the British Medical Association, the medical doctors’ union.

However, 1.3mn appointments have been cancelled because the junior medical doctors’ strike started in December 2022, with greater than 200,000 cancelled in England because of the work stoppages up to now month.

The space of personal medical insurance coverage that has seen the strongest progress has been within the variety of folks taking out private cowl, in accordance with a survey by Statista Consumer Insights, a analysis firm. The share of individuals within the UK aged 18 to 64 with private cowl jumped from 17 per cent in March 2022 to 26 per cent in September final yr, whereas these taking out cowl by means of firm schemes rose from 21 per cent to twenty-eight per cent over the identical interval.

Data from the PHIN signifies that in the course of the pandemic there was a surge in folks paying for personal remedy. This has waned not too long ago as folks have taken out insurance coverage as a substitute, however stays 35 per cent increased than earlier than Covid.

James Daley, managing director of Fairer Finance, a shopper group that charges and critiques monetary providers suppliers, stated the expansion in non-public medical insurance was prone to proceed, though he described the market as “growing from a small base” slightly than “exploding”.

“This is likely even with a change in government [at the next election] because there’s not the flexibility in the public finances to make a big difference to the NHS,” he stated.

However, he warned that because the non-public market grows suppliers will “have to work harder to explain what they’re offering”, notably what’s and isn’t coated.